Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,140.00
Bid: 1,139.00
Ask: 1,144.00
Change: 3.00 (0.26%)
Spread: 5.00 (0.439%)
Open: 1,121.00
High: 1,148.00
Low: 1,121.00
Prev. Close: 1,137.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FCA letter re Release of Preliminary Results

23 Mar 2020 10:59

RNS Number : 1873H
Fevertree Drinks PLC
23 March 2020
 

23rd March 2020

Fevertree Drinks plc

 ("Fever-Tree" or the "Group")

  

FCA letter re Temporary Moratorium on Release of Preliminary Results

The FCA issued guidance on 21 March 2020 requesting public companies to delay the announcement of Preliminary Results for at least two weeks, due to the challenges caused by the Coronavirus crisis. Consequently, while Fever-Tree intended to announce its Preliminary Results for the year ended 31 December 2019 on 24 March 2020, the Group will follow the FCA's request and confirms that it will defer the publication of its results.

Fever-Tree is a global business with revenue diversified across regions, channels and customers. Notwithstanding tough comparators in the UK, the Group has made a solid start to the new financial year, with trading in the first two months in line with the Board's expectations, with the US in particular seeing strong trading.

However, given the current high level of uncertainty it is too early to quantify the impact the COVID-19 crisis will have on the outturn for the remainder of the 2020 financial year and therefore the Board is not able to provide financial guidance at this stage.

Our focus, first and foremost, is on the health and wellbeing of our employees, customers and partners across all our regions. Whilst we will face challenges in the coming months, financially the Group is extremely secure. We are debt free, with a year-end cash position of £128m underpinned by strong cash flows. The Group's unique asset light, outsourced business model means we have a low fixed cost base, a small, dedicated team and the flexibility to manage the significant challenges ahead.

The Group will await further guidance from the FCA with regard to the timing of the publication of its Preliminary Results. 

For further information:

 

Fevertree Drinks plc  +44 (0)20 7349 4922

Tim Warrillow, Co-founder and CEO

Andy Branchflower, CFO

Oliver Winters, Communications & IR Director

 

Numis Securities - Nominated Adviser and Joint Broker +44 (0)20 7260 1000

Garry Levin

Matt Lewis

Hugo Rubinstein

 

Investec Bank plc - Joint Broker +44 (0)20 7597 5970

David Flin

Alex Wright

David Anderson 

 

Brunswick Group +44 (0) 20 7404 5959

Jonathan Glass

Fiona Micallef-Eynaud

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLFEIVIIVFII
Date   Source Headline
13th Nov 20171:37 pmRNSHolding(s) in Company
8th Nov 201711:19 amRNSHolding(s) in Company
7th Nov 20177:00 amRNSTrading Update
3rd Nov 201712:46 pmRNSBlock listing Interim Review
17th Aug 20179:24 amRNSHolding(s) in Company
31st Jul 20174:50 pmRNSHolding(s) in Company
26th Jul 20177:00 amRNSDirector/PDMR Shareholding
25th Jul 201712:03 pmRNSHolding(s) in Company
25th Jul 20177:00 amRNSInterim Results
25th May 20177:00 amRNSResult of Placing in Fevertree Drinks PLC
24th May 20174:35 pmRNSProposed placing of shares in Fevertree Drinks PLC
18th May 20177:00 amRNSGrant of Options
15th May 20175:05 pmRNSResult of AGM
15th May 20177:00 amRNSAGM Statement
25th Apr 201711:05 amRNSHolding(s) in Company
5th Apr 20177:00 amRNS2016 Annual Report and Notice of AGM
21st Mar 20177:00 amRNSPreliminary Results
27th Feb 20172:39 pmRNSHolding(s) in Company
17th Feb 201712:50 pmRNSHolding(s) in Company
30th Jan 201712:37 pmRNSHolding(s) in Company
27th Jan 20174:57 pmRNSHolding(s) in Company
24th Jan 20172:35 pmRNSHolding(s) in Company
24th Jan 20177:00 amRNSTrading Update
15th Nov 20169:31 amRNSHolding(s) in Company
11th Nov 20162:13 pmRNSHolding(s) in Company
7th Nov 20163:58 pmRNSHolding(s) in Company
7th Nov 20167:00 amRNSTrading Statement
26th Oct 20163:35 pmRNSHolding(s) in Company
20th Oct 20165:46 pmRNSHolding(s) in Company
30th Aug 20162:32 pmRNSHolding(s) in Company
26th Aug 20168:21 amRNSHolding(s) in Company
24th Aug 20169:42 amRNSHolding(s) in Company
23rd Aug 20164:59 pmRNSHolding(s) in Company
23rd Aug 20161:35 pmRNSHolding(s) in Company
19th Aug 20162:34 pmRNSHolding(s) in Company
18th Aug 20168:33 amRNSHolding(s) in Company
17th Aug 20169:56 amRNSHolding(s) in Company
5th Aug 201610:02 amRNSHolding(s) in Company
29th Jul 20163:49 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSInterim Results
8th Jun 20165:05 pmRNSHolding(s) in Company
6th Jun 20165:17 pmRNSHolding(s) in Company
26th May 20167:00 amRNSGrant of Options
19th May 20167:00 amRNSTrading Update
21st Apr 20165:48 pmRNSResult of AGM
24th Mar 20167:00 amRNSDirector/PDMR Shareholding
22nd Mar 201610:00 amRNS2015 Annual Report and Notice of AGM
14th Mar 20167:00 amRNSPreliminary Results
29th Feb 20165:30 pmRNSHolding(s) in Company
16th Feb 20167:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.